Retraction
High Expression of RIOK2 and NOB1 Predict Human Non-small Cell Lung Cancer Outcomes
Paper Information
Record ID:
44569
Author(s):
Journal:
Publication Date:
June 27, 2016
Retraction Date:
March 23, 2023
(2.7 years years ago)
Subjects:
Institutions:
Country:
🇨🇳 ChinaArticle Type:
Publisher:
Springer - Nature Publishing Group
Open Access:
Yes
DOI:
PubMed ID:
Retraction PubMed ID:
Retraction Details
Citations (35)
35
Total Citations4
Post-Retraction(11.4%)
31
Pre-Retraction0
Same DayPost-Retraction Citation Analysis
1
Within 30 days
2
Within 1 year
0
After 2+ years
474
Days since retraction (latest)
Increased Expression and Prognostic Significance of BYSL in Melanoma
Zhongzhi Wang, Guo-tai Yao, Liang-zhe Wang et al. (5 authors)
Journal of Immunotherapy
Published: Jul 2024
474 days after retraction
RIO-kinase 2 is essential for hematopoiesis
Jan‐Erik Messling, Isabel Peña‐Rømer, Ann Sophie Moroni et al. (5 authors)
PLoS ONE
Open Access
Published: Apr 2024
1 citation
1 citation
376 days after retraction
Identification of ZMYND19 as a novel biomarker of colorectal cancer: RNA-sequencing and machine learning analysis
Ghazaleh Khalili‐Tanha, Reza Mohit, Alireza Asadnia et al. (14 authors)
Journal of Cell Communication and Signaling
Published: Jul 2023
8 citations
8 citations
109 days after retraction
Progress on the role and mechanism of ribosome assembly regulator PNO1 in tumor
Wanyi Liu, Guicheng Kuang, Binbin Yang et al. (7 authors)
All Life
Open Access
Published: Apr 2023
19 days after retraction
Exploration of tricyclic heterocycles as core structures for RIOK2 inhibitors
Huilan Xiong, Qiuchun Yu, Haowen Ma et al. (9 authors)
RSC Medicinal Chemistry
Published: Jan 2023
4 citations
4 citations
81 days before retraction
RIOK2 Contributes to Cell Growth and Protein Synthesis in Human Oral Squamous Cell Carcinoma
Yusuke Matsuzaki, Yutaka Naito, Nami Miura et al. (9 authors)
Current Oncology
Open Access
Published: Dec 2022
3 citations
3 citations
87 days before retraction
Pan-cancer analyses reveal multi-omics and clinical characteristics of RIO kinase 2 in cancer
Kexin Li, Jiahua Zou, Haizhao Yan et al. (6 authors)
Frontiers in Chemistry
Open Access
Published: Nov 2022
5 citations
5 citations
115 days before retraction
Analysis of RIOK2 Functions in Mediating the Toxic Effects of Deoxynivalenol in Porcine Intestinal Epithelial Cells
Zhongcheng Gao, Chao Xu, Hairui Fan et al. (7 authors)
International Journal of Molecular Sciences
Open Access
Published: Oct 2022
6 citations
6 citations
152 days before retraction
Discovery of 8-(6-Methoxypyridin-3-yl)-1-(4-(piperazin-1-yl)-3-(trifluoromethyl)phenyl)-1,5-dihydro-<i>4H</i>-[1,2,3]triazolo[4,5-<i>c</i>]quinolin-4-one (CQ211) as a Highly Potent and Selective RIOK2 Inhibitor
Yifan Ouyang, Hongfei Si, Chengjun Zhu et al. (12 authors)
Journal of Medicinal Chemistry
Published: May 2022
9 citations
9 citations
309 days before retraction
Targeting RIOK2 ATPase activity leads to decreased protein synthesis and cell death in acute myeloid leukemia
Jan‐Erik Messling, Karl Agger, Kasper Langebjerg Andersen et al. (7 authors)
Blood
Open Access
Published: Aug 2021
23 citations
23 citations
594 days before retraction
Natural products as drugs and tools for influencing core processes of eukaryotic mRNA translation
Luisa D. Burgers, Robert Fürst
Pharmacological Research
Published: May 2021
23 citations
23 citations
663 days before retraction
Similarity and difference of pathogenesis among lung cancer subtypes suggested by expression profile data
Ao Dong, Ziwen Wang, Na Ni et al. (5 authors)
Pathology - Research and Practice
Published: Feb 2021
8 citations
8 citations
771 days before retraction
Natural and Synthetic Lactones Possessing Antitumor Activities
Younghoon Kim, Sandip Sengupta, Taebo Sim
International Journal of Molecular Sciences
Open Access
Published: Jan 2021
24 citations
24 citations
791 days before retraction
BYSL contributes to tumor growth by cooperating with the mTORC2 complex in gliomas
Shangfeng Gao, Zhuang Sha, Junbo Zhou et al. (9 authors)
Cancer Biology and Medicine
Open Access
Published: Jan 2021
24 citations
24 citations
811 days before retraction
Development of Potential Antitumor Agents from the Scaffolds of Plant-Derived Terpenoid Lactones
Yulin Ren, A. Douglas Kinghorn
Journal of Medicinal Chemistry
Open Access
Published: Dec 2020
41 citations
41 citations
835 days before retraction
Towards a RIOK2 chemical probe: cellular potency improvement of a selective 2-(acylamino)pyridine series
C. Wang, Álvaro Lorente‐Macías, Carrow I. Wells et al. (7 authors)
RSC Medicinal Chemistry
Open Access
Published: Nov 2020
4 citations
4 citations
862 days before retraction
Ribosome assembly factor URB1 contributes to colorectal cancer proliferation through transcriptional activation of ATF4
Tao Wang, Laiyuan Li, Yifeng Chen et al. (10 authors)
Cancer Science
Open Access
Published: Sep 2020
15 citations
15 citations
929 days before retraction
RIOK2 is negatively regulated by miR‐4744 and promotes glioma cell migration/invasion through epithelial‐mesenchymal transition
Yunnong Song, Li Cheng, Lei Jin et al. (9 authors)
Journal of Cellular and Molecular Medicine
Open Access
Published: Mar 2020
19 citations
19 citations
1115 days before retraction
Identification of nagilactone E as a protein synthesis inhibitor with anticancer activity
Lele Zhang, Jing Guo, Xiao-ming Jiang et al. (9 authors)
Acta Pharmacologica Sinica
Open Access
Published: Feb 2020
19 citations
19 citations
1136 days before retraction
Paper citing High Expression of RIOK2 and NOB1 Predict Human No...
Unknown Authors
Unknown Journal
Published: Sep 2019
1297 days before retraction
Comprehensive analysis of genomic alterations detected by next‑generation sequencing‑based tissue and circulating tumor DNA assays in Chinese patients with non‑small cell lung cancer
Hua Yang, Junjie Zhang, Lemeng Zhang et al. (14 authors)
Oncology Letters
Open Access
Published: Sep 2019
3 citations
3 citations
1297 days before retraction
Analysis of the Human Kinome and Phosphatome by Mass Cytometry Reveals Overexpression-Induced Effects on Cancer-Related Signaling
Xiao‐Kang Lun, Damian Szklarczyk, Attila Gábor et al. (8 authors)
Molecular Cell
Open Access
Published: May 2019
39 citations
39 citations
1409 days before retraction
Crystal structure of human RIOK2 bound to a specific inhibitor
Jing Wang, Thibault Varin, Michal Vieth et al. (4 authors)
Open Biology
Open Access
Published: Apr 2019
18 citations
18 citations
1452 days before retraction
EBF1-Mediated Upregulation of Ribosome Assembly Factor PNO1 Contributes to Cancer Progression by Negatively Regulating the p53 Signaling Pathway
Aling Shen, Youqin Chen, Liya Liu et al. (15 authors)
Cancer Research
Open Access
Published: Mar 2019
64 citations
64 citations
1472 days before retraction
NOB1: A Potential Biomarker or Target in Cancer
Weiwei Ke, Zaiming Lu, Xiangxuan Zhao
Current Drug Targets
Published: Mar 2019
12 citations
12 citations
1473 days before retraction
Analysis of the human kinome and phosphatome reveals diseased signaling networks induced by overexpression
Xiao‐Kang Lun, Damian Szklarczyk, Attila Gábor et al. (8 authors)
bioRxiv (Cold Spring Harbor Laboratory)
Open Access
Published: May 2018
1784 days before retraction
miR‑145 inhibits human non‑small-cell lung cancer growth by dual-targeting RIOK2 and NOB1
Kun Liu, Honglin Chen, Qingsheng You et al. (10 authors)
International Journal of Oncology
Open Access
Published: May 2018
25 citations
25 citations
1785 days before retraction
microRNA-744 is downregulated in glioblastoma and inhibits the aggressive behaviors by directly targeting NOB1.
Yifan Deng, Yue Li, Qi Fang et al. (5 authors)
PubMed
Published: Jan 2018
18 citations
18 citations
1907 days before retraction
Analysis of the Human Kinome and Phosphatome Reveals Diseased Signaling Networks Induced by Overexpression
Xiao‐Kang Lun, Damian Szklarczyk, Attila Gábor et al. (8 authors)
SSRN Electronic Journal
Open Access
Published: Jan 2018
1907 days before retraction
The atypical protein kinase RIOK3 contributes to glioma cell proliferation/survival, migration/invasion and the AKT/mTOR signaling pathway
Tong Zhang, Daofei Ji, Peng Wang et al. (10 authors)
Cancer Letters
Published: Dec 2017
55 citations
55 citations
1930 days before retraction
MicroRNA-363 inhibits ovarian cancer progression by inhibiting NOB1
Lin Yang, Tianmin Xu, Shunqing Zhou et al. (4 authors)
Oncotarget
Open Access
Published: Sep 2017
29 citations
29 citations
2000 days before retraction
DIMT1 overexpression correlates with progression and prognosis in gastric carcinoma
Guangyi Liu, Xudong Peng, Cai Yong-qian et al. (6 authors)
Human Pathology
Published: Jun 2017
8 citations
8 citations
2115 days before retraction
La synthèse des ribosomes, au cœur du contrôle de la prolifération cellulaire
Clément Madru, Nicolas Leulliot, Simon Lebaron
médecine/sciences
Open Access
Published: Jun 2017
3 citations
3 citations
2121 days before retraction
The Atypical Kinase RIOK1 Promotes Tumor Growth and Invasive Behavior
Florian Weinberg, Nadine Reischmann, Lisa Fauth et al. (19 authors)
EBioMedicine
Open Access
Published: Apr 2017
46 citations
46 citations
2171 days before retraction
Inhibition of NOB1 by microRNA-330-5p overexpression represses cell growth of non-small cell lung cancer
Ranran Kong, Wei Liu, Yurui Guo et al. (14 authors)
Oncology Reports
Open Access
Published: Apr 2017
28 citations
28 citations
2182 days before retraction
Quick Stats
Total Citations:
35
Years Since Retraction:
2.7 years
Open Access:
Yes
Last Checked:
Jul 24, 2025